Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease

Clinical trial NCT07221344 · RECRUITING

Trial details

NCT number: NCT07221344
Sponsor: Arrowhead Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Alzheimer Disease, Early Onset

Start date: 2025-11-18
Primary completion: 2027-06-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.